FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma
Conditions: Diffuse Large B Cell Lymphoma; Transformed Indolent Non-Hodgkin's Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma Interventions: Drug: FT596; Drug: Cyclophosphamide; Drug: Doxorubicin; Drug: Vincristine; Drug: Prednisone; Drug: Rituximab; Drug: Bendamustine Sponsor: Fate Therapeutics Withdrawn
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials